Precision BioSciences Q4 2023 Financial Results: GAAP EPS Misses Expectations, Revenue Significantly Below Forecast
Wednesday, 27 March 2024, 10:51
Precision BioSciences Financial Results for Q4 2023
Precision BioSciences has reported its financial performance for the fourth quarter of 2023, showing a negative GAAP EPS of -$4.06, missing expectations by $2.03. The revenue for the quarter stood at $7.04M but missed forecasts by $7.42M. This indicates notable setbacks in the company's financial outcomes.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.